Women's Health

Women with long or short menstrual cycles are more likely to develop CVD or atrial fibrillation compared with women reporting regular menstrual cycles, but they are no more likely to experience HF or stroke, researchers reported.

BALTIMORE — Repeated use of water-based lubricants did not appear to significantly alter the vaginal microbiome of premenopausal and postmenopausal women for up to 4 weeks after application, researchers reported.

BALTIMORE — New phase 3 data demonstrate efficacy of an investigational next-generation, hormone-free, low-dose copper IUD for prevention of pregnancy through 3 years of use.

BALTIMORE — A special late-breaking session at the ACOG Annual Scientific & Clinical meeting featured the most up-to-date information and guidance on availability of the abortion drug mifepristone.

People who experience adverse pregnancy outcomes develop cerebrovascular disease at younger ages, with the earliest onset and greatest risk seen in those with multiple pregnancies affected by complications, researchers reported.

BALTIMORE — A one-time dose of off-label cabergoline after second-trimester abortion or pregnancy loss was effective for preventing symptomatic breast engorgement, according to data presented at the ACOG Annual Clinical & Scientific Meeting.

BALTIMORE — Patients with heavy menstrual bleeding who received the levonorgestrel 52 mg intrauterine device experienced significant and rapid decreases in uterine bleeding after placement, a researcher reported here.

BALTIMORE — Instagram is being used to distribute accurate and inaccurate medical information about abortion by both medical and nonmedical professionals, researchers reported at the ACOG Annual Clinical & Scientific Meeting.

For National Women’s Health Week, Healio Editors compiled news on pregnancy.

The ACOG Annual Clinical & Scientific Meeting will have a heavy focus on overcoming current challenges, including diversity, equity and inclusion, in women’s health.